{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:10:05Z","timestamp":1749553805204,"version":"3.41.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Randomized trials have progressively enabled the de-escalation of axillary surgery in breast cancer (BC) patients, reducing adverse events without compromising survival. Despite a not negligible rate of residual disease in the axilla after sentinel lymph node (SLN) procedure, the risk of regional lymph node recurrence (RLNR) is very low, due probably to multimodal adjuvant treatments. The characteristics of the small number of patients with RLNR remain poorly characterized and warrant further investigation, especially given their poor prognosis and the current context of ongoing studies exploring further de-escalation of axillary surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective and single institution study, we analyzed thoroughly a cohort of patients who experienced RLNR as first event between 2009 and 2020. MammaPrint and BluePrint analysis (MB) was performed in available primary invasive cancer tissues.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty patients, median age of 52, were analyzed. Disease-free interval was 8.7\u00a0years. Most of the patients (65%) had no special type BC. Majority (73%) had hormone receptor positive-HER2 negative (HR\u2009+\u2009\/HER2\u2212) BC, 13% triple negative (TNBC), 6% HER2\u2009+\u2009, 8% ductal carcinoma in situ and 3% unknown. The median size of the primary tumor was 1.8\u00a0cm (range 0.3\u20137.0) and 57% had no initial LN involvement. Forty five percent had primary SLN procedure and 53% axillary LN dissection (ALND) of the patients received neo-\/adjuvant chemotherapy, 63% endocrine therapy and 68% radiotherapy (50% only in breast). Sixty three percent had only RLNR and 38% had concomitant distant metastases. Among irradiated patients, 63% had some relapse in the radiation field. The MB analysis classified 70% of the analyzed cancers as low-risk luminal A (82% in HR\u2009+\u2009\/HER2\u2212), 15% high-risk luminal B, 10% high-risk basal type, and 5% high-risk HER2 type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study confirms that patients treated with SLN do not show a higher risk of LRNR compared to ALND. LRNR is often diagnosed incidentally. Younger age, residual disease post-NAC, no regional radiation, stage II, and initial LN involvement were more represented, as well as patients with endocrine sensitive disease classified as low-risk luminal A by MB. Ongoing trials, including SOUND, INSEMA, and BOOG 2013-08, are further exploring axillary surgery de-escalation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00432-025-06235-5","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:18:45Z","timestamp":1748517525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study)"],"prefix":"10.1007","volume":"151","author":[{"given":"Aikaterini","family":"Liapi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Aedo-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Jeanneret-Sozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Stravodimou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John O.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Nicod","family":"Lalonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assia Ifticene","family":"Treboux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Lelievre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Kandalaft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Rossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Goupil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzio","family":"Bergomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Rivals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Brouland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Curtit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Meuwly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"issue":"8","key":"6235_CR1","doi-asserted-by":"publisher","first-page":"e2013226","DOI":"10.1001\/jamanetworkopen.2020.13226","volume":"3","author":"T Acheampong","year":"2020","unstructured":"Acheampong T, Kehm RD, Terry MB et al (2020) Incidence trends of breast cancer molecular subtypes by age and race\/ethnicity in the US from 2010 to 2016. JAMA Netw Open 3(8):e2013226\u2013e2013236. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.13226","journal-title":"JAMA Netw Open"},{"issue":"1","key":"6235_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamaoncol.2023.4837","volume":"10","author":"JD Benitez Fuentes","year":"2023","unstructured":"Benitez Fuentes JD, Morgan E, de Luna AA et al (2023) Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis. JAMA Oncol 10(1):71\u201378. https:\/\/doi.org\/10.1001\/jamaoncol.2023.4837","journal-title":"JAMA Oncol"},{"issue":"10","key":"6235_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18790","volume":"3","author":"A Bitencourt","year":"2020","unstructured":"Bitencourt A, Rossi Saccarelli C, Morris EA et al (2020) Regional lymph node involvement among patients with de novo metastatic breast cancer. JAMA Netw Open 3(10):e2018790. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.18790","journal-title":"JAMA Netw Open"},{"issue":"11","key":"6235_CR4","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1245\/s10434-023-13759-y","volume":"30","author":"JC Boughey","year":"2023","unstructured":"Boughey JC, Yu H, Lu Dugan C et al (2023) Changes in surgical management of the axilla Over 11 Years\u2014report on more than 1500 breast cancer patients treated with neoadjuvant chemotherapy on the prospective I-SPY2 trial. Ann Surg Oncol 30(11):6401\u20136410. https:\/\/doi.org\/10.1245\/s10434-023-13759-y","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"6235_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","volume":"34","author":"G Curigliano","year":"2023","unstructured":"Curigliano G, Burstein HJ, Gnant M et al (2023) Understanding breast cancer complexity to improve patient outcomes: the St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol 34(11):970\u2013986. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.017","journal-title":"Ann Oncol"},{"issue":"2","key":"6235_CR6","doi-asserted-by":"publisher","first-page":"zrac022","DOI":"10.1093\/bjsopen\/zrac022","volume":"6","author":"MG Davey","year":"2022","unstructured":"Davey MG, O\u2019Flaherty C, Cleere EF et al (2022) Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis. BJS Open 6(2):zrac022. https:\/\/doi.org\/10.1093\/bjsopen\/zrac022","journal-title":"BJS Open"},{"issue":"13","key":"6235_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Filtenborg Tvedskov T, Ryd\u00e9n L et al (2024) Omitting axillary dissection in breast cancer with sentinel-node metastases. N Eng J Med 390(13):1163\u20131775. https:\/\/doi.org\/10.1056\/NEJMoa2313487","journal-title":"N Eng J Med"},{"issue":"12","key":"6235_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomized, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303\u20131310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"issue":"3","key":"6235_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10549-014-3188-z","volume":"148","author":"CA Drukker","year":"2014","unstructured":"Drukker CA, Elias SG, Nijenhuis MV et al (2014) Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis. Breast Cancer Res Treat 148(3):599\u2013613. https:\/\/doi.org\/10.1007\/s10549-014-3188-z","journal-title":"Breast Cancer Res Treat"},{"key":"6235_CR10","unstructured":"Federal Act on Research involving Human Beings (2011) The Federal Assembly of the Swiss Confederation. [Accessed November 2024]. Available from: https:\/\/www.fedlex.admin.ch\/eli\/cc\/2013\/617\/en"},{"key":"6235_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3759","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R et al (2023) Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759","journal-title":"JAMA Oncol"},{"issue":"3","key":"6235_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L et al (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. Ann Surg 264(3):413\u2013420. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32","journal-title":"Ann Surg"},{"issue":"10","key":"6235_CR13","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1245\/s10434-023-13885-7","volume":"30","author":"J Horan","year":"2023","unstructured":"Horan J, Reid C, Boland MR et al (2023) Assessing mode of recurrence in breast cancer to identify an optimised follow-up pathway: 10-year institutional review. Ann Surg Oncol 30(10):6117\u20136124. https:\/\/doi.org\/10.1245\/s10434-023-13885-7","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"6235_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/jco.2012.45.9859","volume":"31","author":"JL Khatcheressian","year":"2013","unstructured":"Khatcheressian JL, Hurley P, Bantug E et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31(7):961\u2013965. https:\/\/doi.org\/10.1200\/jco.2012.45.9859","journal-title":"J Clin Oncol"},{"key":"6235_CR15","unstructured":"Schweizer Krebsbulletin. 2015 Effects of age and stage on breast cancer survival in Switzerland. [Accessed November 2024]. Available from: https:\/\/www.nicer.org\/assets\/files\/publications\/others\/skb_2-2015_breastcancer_survival_ch.pdf"},{"issue":"7","key":"6235_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1177\/0284185118805264","volume":"60","author":"BR Kwon","year":"2018","unstructured":"Kwon BR, Chang JM, Lee J et al (2018) Detection of axillary lymph node recurrence in patients with personal history of breast cancer treated with sentinel lymph node biopsy (SLNB): results of postoperative combined ultrasound and mammography screening over five consecutive years. Acta Radiol 60(7):852\u2013858. https:\/\/doi.org\/10.1177\/0284185118805264","journal-title":"Acta Radiol"},{"issue":"8","key":"6235_CR17","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1245\/s10434-014-4321-2","volume":"22","author":"RM Lanning","year":"2015","unstructured":"Lanning RM, Morrow M, Riaz N et al (2015) The effect of adjuvant trastuzumab on locoregional recurrence of human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy. Ann Surg Oncol 22(8):2517\u20131225. https:\/\/doi.org\/10.1245\/s10434-014-4321-2","journal-title":"Ann Surg Oncol"},{"key":"6235_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","author":"S Loibl","year":"2023","unstructured":"Loibl S, Varga A, Bachelot T, Barrios CH, Bergh J, Burstein HJ et al (2023) Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.016","journal-title":"Ann Oncol"},{"issue":"20","key":"6235_CR19","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.19.02905","volume":"38","author":"EP Mamounas","year":"2020","unstructured":"Mamounas EP, Mitchell MP, Woodward WA (2020) Molecular predictive and prognostic markers in locoregional management. J Clin Oncol 38(20):2310\u20132320. https:\/\/doi.org\/10.1200\/JCO.19.02905","journal-title":"J Clin Oncol"},{"issue":"2","key":"6235_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4048\/jbc.2015.18.2.143","volume":"18","author":"MD Mattes","year":"2015","unstructured":"Mattes MD, Bhatia JK, Metzger D et al (2015) Breast cancer subtype as a predictor of lymph node metastasis according to the SEER registry. J Breast Cancer 18(2):143\u2013148. https:\/\/doi.org\/10.4048\/jbc.2015.18.2.143","journal-title":"J Breast Cancer"},{"issue":"2","key":"6235_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/annonc\/mdr129","volume":"23","author":"E Montagna","year":"2012","unstructured":"Montagna E, Bagnardi V, Rotmensz N, Viale G, Renne G, Cancello G et al (2012) Breast cancer subtypes and outcome after local and regional relapse. Ann Oncol 23(2):324\u2013331","journal-title":"Ann Oncol"},{"issue":"3","key":"6235_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.adro.2017.04.008","volume":"2","author":"AC Moreno","year":"2017","unstructured":"Moreno AC, Yan HL, Bedrosian I et al (2017) Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: a national cancer database analysis. Adv Radiat Oncol 2(3):291\u2013300. https:\/\/doi.org\/10.1016\/j.adro.2017.04.008","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"6235_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1200\/JCO.23.01009","volume":"42","author":"GE Naoum","year":"2024","unstructured":"Naoum GE, Oladeru O, Ababneh H et al (2024) Pathologic Exploration of the axillary soft tissue microenvironment and its impact on axillary management and breast cancer outcomes. J Clin Oncol 42(2):157\u2013169. https:\/\/doi.org\/10.1200\/JCO.23.01009","journal-title":"J Clin Oncol"},{"issue":"14","key":"6235_CR24","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","volume":"26","author":"PL Nguyen","year":"2008","unstructured":"Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 Is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26(14):2373\u20132378. https:\/\/doi.org\/10.1200\/JCO.2007.14.4287","journal-title":"J Clin Oncol"},{"issue":"5","key":"6235_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","volume":"22","author":"R Orecchia","year":"2021","unstructured":"Orecchia R, Veronesi U, Maisonneuve P et al (2021) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomized, phase 3 equivalence trial. Lancet Oncol 22(5):597\u2013608. https:\/\/doi.org\/10.1016\/S1470-2045(21)00080-2","journal-title":"Lancet Oncol"},{"issue":"1","key":"6235_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha EA, Tse GM, Quinn CM (2023) An update on the pathological classification of breast cancer. Histopathology 82(1):5\u201316. https:\/\/doi.org\/10.1111\/his.14786","journal-title":"Histopathology"},{"key":"6235_CR27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2412063","author":"T Reimer","year":"2024","unstructured":"Reimer T, Stachs A, Veselinovic K, K\u00fchn T, Heil J, Polata S et al (2024) Axillary surgery in breast cancer\u2014primary results of the INSEMA trial. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmoa2412063","journal-title":"N Engl J Med"},{"issue":"1","key":"6235_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12893-021-01170-x","volume":"21","author":"YD Shin","year":"2021","unstructured":"Shin YD, Lee HM, Choi YJ (2021) Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis. BMC Surg 21(1):159. https:\/\/doi.org\/10.1186\/s12893-021-01170-x","journal-title":"BMC Surg"},{"issue":"1","key":"6235_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"6235_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.44212","volume":"5","author":"D Smith","year":"2022","unstructured":"Smith D, Sepehr S, Karakatsanis A et al (2022) Yield of surveillance imaging after mastectomy with or without reconstruction for patients with prior breast cancer: a systematic review and meta-analysis. JAMA Netw Open 5(12):e2244212. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44212","journal-title":"JAMA Netw Open"},{"issue":"4","key":"6235_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1245\/ASO.2006.05.015","volume":"13","author":"HC Snider","year":"2006","unstructured":"Snider HC, Rubin E, Henson R (2006) Axillary ultrasonography to detect recurrence after sentinel node biopsy in breast cancer. Ann Surg Oncol 13(4):501\u2013507. https:\/\/doi.org\/10.1245\/ASO.2006.05.015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"6235_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamasurg.2018.0035","volume":"153","author":"SM Stapleton","year":"2018","unstructured":"Stapleton SM, Oseni TO, Bababekov YJ et al (2018) Race\/ethnicity and age distribution of breast cancer diagnosis in the United States. JAMA Surg 153(6):594\u2013595. https:\/\/doi.org\/10.1001\/jamasurg.2018.0035","journal-title":"JAMA Surg"},{"issue":"10416","key":"6235_CR33","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","volume":"402","author":"C Taylor","year":"2023","unstructured":"Taylor C, Dodwell D, McGale P et al (2023) Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Lancet 402(10416):1991\u20132003. https:\/\/doi.org\/10.1016\/S0140-6736(23)01082-6","journal-title":"Lancet"},{"issue":"7","key":"6235_CR34","doi-asserted-by":"publisher","first-page":"e818","DOI":"10.1016\/j.clbc.2022.06.003","volume":"22","author":"SM Tun","year":"2022","unstructured":"Tun SM, Alluri S, Rastegar V et al (2022) Mode of detection of second events in routine surveillance of early stage breast cancer patients. Clin Breast Cancer 22(7):e818\u2013e824. https:\/\/doi.org\/10.1016\/j.clbc.2022.06.003","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"6235_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejso.2008.01.034","volume":"34","author":"IMC van der Ploeg","year":"2008","unstructured":"van der Ploeg IMC, Nieweg OE, van Rijk MC et al (2008) Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34(12):1277\u20131284. https:\/\/doi.org\/10.1016\/j.ejso.2008.01.034","journal-title":"Eur J Surg Oncol"},{"issue":"16_suppl","key":"6235_CR36","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1200\/JCO.2024.42.16_suppl.514","volume":"42","author":"A van Hemert","year":"2024","unstructured":"van Hemert A, van Loevezijn A, Baas MS et al (2024) Oncologic outcome of response-guided axillary treatment in patients with cN1 breast cancer after primary systemic therapy. J Clin Oncol 42(16_suppl):514. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.514","journal-title":"J Clin Oncol"},{"issue":"13","key":"6235_CR37","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","volume":"24","author":"IL Wapnir","year":"2006","unstructured":"Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE, Jeong JH, Tan-Chiu E et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028\u20132037","journal-title":"J Clin Oncol"},{"issue":"10","key":"6235_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamasurg.2023.2840","volume":"158","author":"WP Weber","year":"2023","unstructured":"Weber WP, Matrai Z, Hayoz S et al (2023) Association of axillary dissection with systemic therapy in patients with clinically node-positive breast cancer. JAMA Surg 158(10):1013\u20131021. https:\/\/doi.org\/10.1001\/jamasurg.2023.2840","journal-title":"JAMA Surg"},{"key":"6235_CR39","unstructured":"World Medical Association (2024) The World Medical Association-WMA Declaration of Helsinki\u2014Ethical Principles for Medical Research Involving Human Subjects [Accessed November 2024]. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06235-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:32:35Z","timestamp":1749551555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06235-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["6235"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06235-5","relation":{},"ISSN":["1432-1335"],"issn-type":[{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Cantonal Commission for Ethics in Research on Human Beings (CER-VD No 2020-00131).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"176"}}